enGene Holdings Inc. (ENGN)
(Delayed Data from NSDQ)
$6.50 USD
-0.08 (-1.22%)
Updated Sep 10, 2024 04:00 PM ET
After-Market: $6.45 -0.05 (-0.77%) 7:58 PM ET
3-Hold of 5 3
D Value B Growth F Momentum D VGM
Income Statements
Fiscal Year end for enGene Holdings Inc falls in the month of October .
All items in Millions except EPS data.
10/31/23 | 10/31/22 | 10/31/21 | 10/31/20 | 10/31/19 | |
---|---|---|---|---|---|
Sales | 0 | 0 | 0 | NA | NA |
Cost Of Goods | 0 | 0 | 0 | NA | NA |
Gross Profit | 0 | 0 | 0 | NA | NA |
Selling & Adminstrative & Depr. & Amort Expenses | 26 | 17 | 0 | 0 | 0 |
Income After Depreciation & Amortization | -26 | -17 | 0 | 0 | 0 |
Non-Operating Income | -69 | 2 | 0 | NA | NA |
Interest Expense | 5 | 1 | 0 | NA | NA |
Pretax Income | -100 | 0 | 0 | NA | NA |
Income Taxes | 0 | 0 | 0 | NA | NA |
Minority Interest | 0 | 0 | 0 | NA | NA |
Investment Gains/Losses | 0 | 0 | 0 | NA | NA |
Other Income/Charges | 0 | 0 | 0 | NA | NA |
Income From Cont. Operations | -100 | 0 | 0 | NA | NA |
Extras & Discontinued Operations | 0 | 0 | 0 | NA | NA |
Net Income (GAAP) | -100 | 0 | 0 | NA | NA |
Depreciation Footnote | 10/31/23 | 10/31/22 | 10/31/21 | 10/31/20 | 10/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | -26 | -17 | 0 | 0 | 0 |
Depreciation & Amortization (Cash Flow) | 0 | 0 | 0 | NA | NA |
Income After Depreciation & Amortization | -26 | -17 | 0 | 0 | 0 |
Earnings Per Share Data | 10/31/23 | 10/31/22 | 10/31/21 | 10/31/20 | 10/31/19 |
---|---|---|---|---|---|
Average Shares | 0.69 | NA | NA | NA | NA |
Diluted EPS Before Non-Recurring Items | 151.22 | NA | NA | NA | NA |
Diluted Net EPS (GAAP) | -151.22 | NA | NA | NA | NA |
Fiscal Year end for enGene Holdings Inc falls in the month of October .
All items in Millions except EPS data.
7/31/24 | 4/30/24 | 1/31/24 | 10/31/23 | 7/31/23 | |
---|---|---|---|---|---|
Sales | NA | 0.00 | 0.00 | NA | 0.00 |
Cost Of Goods | NA | 0.00 | 0.00 | NA | 0.00 |
Gross Profit | NA | 0.00 | 0.00 | NA | 0.00 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 17.32 | 10.78 | 0.00 | 2.57 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | -17.32 | -10.78 | 0.00 | -2.57 |
Non-Operating Income | NA | 3.08 | 0.60 | -3.66 | 1.79 |
Interest Expense | NA | 0.73 | 0.56 | NA | 0.00 |
Pretax Income | NA | -14.96 | -10.74 | -96.05 | -0.79 |
Income Taxes | NA | 0.02 | -0.03 | NA | 0.00 |
Minority Interest | NA | 0.00 | 0.00 | NA | 0.00 |
Investment Gains/Losses | NA | 0.00 | 0.00 | NA | 0.00 |
Other Income/Charges | NA | 0.00 | 0.00 | NA | 0.00 |
Income From Cont. Operations | NA | -14.98 | -10.71 | -89.44 | -0.79 |
Extras & Discontinued Operations | NA | 0.00 | 0.00 | NA | 0.00 |
Net Income (GAAP) | NA | -14.98 | -10.71 | -89.44 | -0.79 |
Earnings Per Share Data | 7/31/24 | 4/30/24 | 1/31/24 | 10/31/23 | 7/31/23 |
---|---|---|---|---|---|
Average Shares | NA | 39.44 | 23.20 | NA | NA |
Diluted EPS Before Non-Recurring Items | NA | -0.38 | 0.46 | NA | NA |
Diluted Net EPS (GAAP) | NA | -0.38 | -0.46 | -150.98 | -0.05 |